Pimecrolimus is a topical calcineurin inhibitor used to treat inflammatory skin conditions such as atopic dermatitis (eczema). It works by blocking the release of chemicals that cause inflammation in the skin. Pimecrolimus is available as a cream or ointment and is applied to the affected area of skin two or three times a day. Common side effects of pimecrolimus include burning or stinging at the application site, dry skin, and redness.
Pimecrolimus is a topical medication used to treat eczema (atopic dermatitis) [WebMD]. It's a prescription medication prescribed for people who either can't use other eczema medications, like topical steroids, or haven't seen improvement with those treatments. Here's a breakdown of what pimecrolimus is and how it works:
Type of drug: Topical calcineurin inhibitor (TCI)
How it works: Pimecrolimus works by suppressing the immune system's response in the skin. This helps to reduce inflammation, redness, and itching associated with eczema. The exact mechanism isn't fully understood, but it targets certain immune system cells like T-cells and mast cells.
What it's used for: Pimecrolimus is specifically for mild to moderate eczema in people who can't use or haven't responded well to other treatments [MedlinePlus].
Things to consider:
- Pimecrolimus comes as a cream applied directly to the affected skin, typically twice a day for up to 6 weeks [MedlinePlus].
- It's not a first-line treatment for eczema and should only be used under a doctor's supervision.
- There can be side effects, though generally mild, like burning or stinging at the application site [WebMD].
- Pimecrolimus is not recommended for children under 2 years old or people with a specific genetic disorder called Netherton's syndrome [WebMD].